Does Mounjaro work a second time around?

Receptor sensitivity to tirzepatide does not appear to be durably reduced by a previous course, the body can respond again on restarting.
Clinical guidance recommends restarting at the lowest tolerated dose, not the dose you were on when you stopped, to manage side-effect risk.
Weight regain after stopping is common and does not mean the medicine failed; it reflects the biology of a chronic condition, not personal failure.
A same-day clinical review by a GPhC-registered prescriber determines whether restarting is appropriate for your current health picture.

Yes, Mounjaro can work again if you restart it. Most people who regain weight after stopping tirzepatide do respond when they begin again, because the underlying mechanism — dual activation of GIP and GLP-1 receptors — does not become permanently less effective simply from prior use. That said, restarting is not a straight continuation; there are real factors that shape how well it goes. Mounjaro is a prescription-only medicine, so a prescriber assesses your situation before any course, first or subsequent, begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually tells us about restarting tirzepatide

The biggest misconception: that Mounjaro 'stops working' and restarting is pointless

The most persistent misunderstanding around restarting Mounjaro is the idea that the medicine wore itself out the first time, or that your body has become permanently resistant to it. This is not what the evidence shows. Tirzepatide works by activating GIP and GLP-1 receptors involved in appetite regulation and gastric emptying. Those receptors do not switch off because you used tirzepatide before.

What does happen when you stop is well-documented. Appetite and food intake tend to return toward baseline, and for many people weight does too. A large part of what gets labelled 'Mounjaro stopped working' is actually weight returning after stopping, a different thing entirely. The medicine's mechanism is not diminished; the effect simply required the medicine to be present. You can read more about how tirzepatide's dual-agonist action works if that distinction is useful.

Where genuine 'secondary non-response' can occur (a plateau despite continued treatment) that tends to be metabolic adaptation over time, not receptor burnout specific to previous courses. A prescriber can review whether that applies to your situation before committing to a restart.

Why the restart experience can feel different from the first course

Plenty of people notice that restarting does not feel identical to starting the first time, even when the medicine is working. A few things explain this. First, your starting point is different, body weight, metabolic rate, and any dietary habits you kept or dropped since stopping all influence early response. Second, if significant time passed between stopping and restarting, your system is essentially encountering the medicine fresh again, which means the early gastrointestinal effects (nausea, loose stools, indigestion) may return with similar intensity to the first course.

This matters for dose. Clinical guidance is clear that restarting should begin at a low dose rather than picking up where you left off. The first few weeks back on treatment are a recalibration period, not a slower version of the original titration. There is also a practical question of where you are hormonally, how much weight you are trying to lose this time, and whether any new health factors have emerged since you last used it. A prescriber will go through all of this.

The NHS page on tirzepatide covers what to expect with the medicine generally, including the common GI effects that often accompany dose changes.

How quickly does Mounjaro work on a second course?

There is no separate trial data specifically for restarting patients, so timelines are informed by the general evidence on how tirzepatide takes effect alongside clinical experience. If you want a detailed breakdown of those timelines, our page on how long tirzepatide typically takes to work covers the phases from first dose through to meaningful weight change. The short version is that appetite suppression often becomes noticeable within the first few weeks, while meaningful weight change typically takes a month or more, depending on dose and individual response.

One thing worth being realistic about: if you restart at 2.5mg (the appropriate starting point for tolerability reasons), the first pen's job is to settle your system, not to produce dramatic results. If you are unsure what to expect week by week, our page on how long Mounjaro takes to work walks through what typically happens at each stage of treatment. Patience in the titration phase matters as much the second time as the first.

If you want to understand how the wider tirzepatide programme approaches effectiveness, the SURMOUNT trials, discussed in NICE's appraisal of tirzepatide (TA1026), provide the robust basis for what clinicians expect the medicine to achieve, though those figures come from participants on full titration courses, not restart scenarios specifically.

What a prescriber looks at before approving a restart

Getting Mounjaro again is not simply a repeat order. A GPhC-registered prescriber reviews your current health, weight, and any changes since your previous course before deciding whether restarting is clinically appropriate. This includes checking whether your BMI and any weight-related conditions still meet the licensed criteria, reviewing any new medicines or conditions that might affect suitability, and confirming you understand the commitment required, including lifestyle changes alongside treatment. For anyone weighing up whether a second course is worth pursuing, our page on whether Mounjaro is as effective second time round addresses that question directly using the available evidence.

For those considering the cost of a further course, Mounjaro cost context explains what private treatment involves and what one transparent price covers. At nume, every repeat is reviewed by a real clinician, not an automated system, your case is read individually before anything is dispensed. Treatment arrives from a GPhC-registered pharmacy, typically via DPD next working day in plain, unbranded packaging with a tracking link sent to your phone.

If you have questions before deciding, our FAQs cover common points, or you can reach our clinical team directly. Whenever you're ready to take the next step, start your free consultation and a prescriber will review your situation the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions